Proto Labs Inc (PRLB)

Proto Labs, Inc. is an industrial company that provides digital manufacturing services for custom parts in the United States and Europe. Through its subsidiaries, the company supports developers, engineers, and supply chain teams with capabilities that include molding, computer numerical control machining, 3D printing, and sheet metal fabrication. Founded in 1999 and headquartered in Maple Plain, Minnesota, Proto Labs is listed on the New York Stock Exchange under the common stock symbol PRLB.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-PRLB
$63.57
-28.9% Downside
Overvalued
$95.50
6.8% Upside
Fair
Good
0.0%
October 30, 2026
70.2x
3.1x
3.8x
2.14 B
1.979 B
0.1%
98.8%
15.5
185.9%
Valuation • Fair Value

Proto Labs Inc (NYSE-PRLB) Fair Value by Valuation Model

Review the available estimates for Proto Labs Inc (NYSE-PRLB), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$63.57

Estimated downside of 28.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$53.40

Discounted cash flow valuation reference.

Ben Graham Formula Value

$14.14

Classic Ben Graham valuation formula reference.

Comps Fair Value

$73.74

Comparable-company valuation reference.

Analyst Price Target

$95.50

Analysts imply upside of 6.8%.

How to read these valuation models

Use the 6 available valuation references for Proto Labs Inc (NYSE-PRLB) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Proto Labs Inc (NYSE-PRLB)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

560.5 M

Current operating scale indicator.

Revenue Forecast

581.5 M

Forward revenue estimate.

EBITDA

74.11 M

Current operating profitability reference.

EBITDA Forecast

95.481 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Proto Labs Inc (NYSE-PRLB) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Proto Labs Inc (NYSE-PRLB)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.64

No elevated caution signal from this screen.

Altman Z-Score

15.5

Relatively strong balance-sheet zone.

FCF / Net Income

185.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Proto Labs Inc (NYSE-PRLB). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Proto Labs Inc (NYSE-PRLB)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 30, 2026

Days to Earnings

38

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Proto Labs Inc (NYSE-PRLB), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Proto Labs Inc (NYSE-PRLB) Stock Forecast & Technical Outlook

Review Proto Labs Inc (NYSE-PRLB) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Proto Labs Inc (NYSE-PRLB) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Proto Labs Inc (NYSE-PRLB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Proto Labs Inc (NYSE-PRLB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Proto Labs Inc (NYSE-PRLB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Proto Labs Inc (NYSE-PRLB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Proto Labs Inc (NYSE-PRLB)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Proto Labs Inc (NYSE-PRLB) has a Strong Buy consensus, with 3 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 3
Hold 1
Sell 0
FAQ Fast Investor Answers

Proto Labs Inc (NYSE-PRLB) Stock FAQ

Data-supported answers about Proto Labs Inc (NYSE-PRLB), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$63.57
Estimated downside 28.9%
Valuation Rating
Overvalued
Estimated downside of 28.9%
Analyst Target
$95.50
Implied upside 6.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Proto Labs Inc (NYSE-PRLB) is $63.57. This implies an estimated downside of 28.9% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 28.9% versus the current market price.

The available analyst price target for Proto Labs Inc (NYSE-PRLB) is $95.50. The analyst target implies estimated upside of 6.8%.

The current financial health read for Proto Labs Inc (NYSE-PRLB) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Proto Labs Inc (NYSE-PRLB) is October 30, 2026.

The latest available data indicates no current dividend yield for Proto Labs Inc (NYSE-PRLB).

The current P/E ratio listed for Proto Labs Inc (NYSE-PRLB) is 70.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Proto Labs Inc is 2.14 B.

The current enterprise value listed for Proto Labs Inc is 1.979 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Proto Labs Inc is NYSE-PRLB, and the stock is listed on NYSE.

Proto Labs Inc (NYSE-PRLB) is listed on NYSE.

The current debt-to-total-capital ratio listed for Proto Labs Inc is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Proto Labs Inc is 98.8%. Free float helps investors understand how much of the share base is available for public trading.